Cargando…
eHealth in Modern Patient-Caregiver Communication: High Rate of Acceptance Among Physicians for Additional Support of Breast Cancer Patients During Long-Term Therapy
BACKGROUND: Lack of adherence and compliance with drug regimens among breast cancer patients represent substantial problems in oral therapies, leading to significant impacts on mortality. Where other systems have failed, electronic health (eHealth) could be a possible solution to improve medication...
Autores principales: | Kirkovits, Thomas, Schinkoethe, Timo, Drewes, Caroline, Gehring, Caroline, Bauerfeind, Ingo, Harbeck, Nadia, Wuerstlein, Rachel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367844/ https://www.ncbi.nlm.nih.gov/pubmed/28410173 http://dx.doi.org/10.2196/cancer.5132 |
Ejemplares similares
-
EHealth Acceptance and New Media Preferences for Therapy Assistance Among Breast Cancer Patients
por: Drewes, Caroline, et al.
Publicado: (2016) -
Clinical relevance of potential self-medication drug interactions in antineoplastic and immune-modulating therapy among online pharmacy customers
por: Schindler, Florian, et al.
Publicado: (2023) -
WSG ADAPT – adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigator initiated phase II/III trial
por: Hofmann, Daniel, et al.
Publicado: (2013) -
Recover your smile: Effects of a beauty care intervention on depressive symptoms, quality of life, and self‐esteem in patients with early breast cancer
por: Richard, Anna, et al.
Publicado: (2018) -
Determining the Influencing Factors on Acceptance of eHealth Pain Management Interventions Among Patients With Chronic Pain Using the Unified Theory of Acceptance and Use of Technology: Cross-sectional Study
por: Stoppok, Paula, et al.
Publicado: (2022)